Skip to main content
Top
Published in: BMC Infectious Diseases 1/2022

Open Access 01-12-2022 | Malaria | Study protocol

Reducing malaria transmission in forest-going mobile and migrant populations in Lao PDR and Cambodia: protocol for stepped-wedge cluster-randomised controlled trial

Authors: Win Htike, Win Han Oo, Thet Lynn, Lun Sovanda, Paul A. Agius, May Chan Oo, Naw Hkawng Galau, Kaung Myat Thu, Aung Khine Zaw, Ei Phyu Htwe, Julia C. Cutts, Ellen A. Kearney, Nick Scott, Katherine O’Flaherty, Bangyuan Wang, Boualam Khamlome, Phoutnalong Vilay, Sovannaroth Siv, Freya J. I. Fowkes

Published in: BMC Infectious Diseases | Issue 1/2022

Login to get access

Abstract

Background

Countries of the Greater Mekong Sub-region aim to achieve malaria elimination by 2030. In the region, malaria is concentrated in high-risk areas and populations such as forest-going mobile and migrant populations (MMPs). However, routine protective measures such as long-lasting insecticidal nets do not prevent all infectious bites in these high-risk populations. Evidence for the effectiveness of a personal protection package tailored to forest-going MMPs which is acceptable, feasible, and cost-effective for reducing malaria transmission is required to inform the malaria elimination toolkit in the region.

Methods

A personal protection package consisting of long-lasting insecticidal hammock net, insect repellent and health communication pamphlet was developed in consultation with relevant implementing partners from Cambodia and Lao PDR. An open stepped-wedge cluster-randomised controlled trial will be conducted over a period of 12 months in a minimum of 488 villages (~ 428 in Lao PDR and ~ 60 in Cambodia) to evaluate the effectiveness of the personal protection package. Villages will be randomised into 11 blocks, with blocks transitioned in random order from control to intervention states at monthly intervals, following a 1-month baseline period. The primary outcome of the trial is the prevalence of Plasmodium spp. infection diagnosed by rapid diagnostic test. Difference in prevalence of malaria infection will be estimated across intervention and control periods using generalized linear mixed modelling. Nested within the stepped-wedge cluster-randomised controlled trial is a mixed-methods study to explore the acceptability of the personal protection package, feasibility of implementing a personal protection package as a vector control intervention, and knowledge, attitude and practice of MMPs regarding malaria prevention; and cost-analysis to determine the cost-effectiveness of implementing a personal protection package.

Discussion

This study, using a rigorous design and mixed-methods methodology, will evaluate whether a personal protection package can reduce residual malaria transmission among forest-going MMPs in Cambodia and Lao PDR. It will also measure implementation research outcomes such as effectiveness of the intervention package, cost-effectiveness, acceptability, and feasibility, in order to inform potential national and regional policy.
Trial registration This trial was prospectively registered on ClinicalTrials.gov (NCT05117567) on 11th November 2021
Appendix
Available only for authorised users
Literature
1.
go back to reference World Health Organization. World Malaria Report 2014. Geneva: World Health Organization; 2014.CrossRef World Health Organization. World Malaria Report 2014. Geneva: World Health Organization; 2014.CrossRef
2.
go back to reference World Health Organization. World Malaria Report 2021. Geneva: World Health Organization; 2021.CrossRef World Health Organization. World Malaria Report 2021. Geneva: World Health Organization; 2021.CrossRef
3.
go back to reference Win Han Oo, Hoban E, Gold L, Kyu Kyu T, Thazin L, Aung T, Fowkes FJI: Community demand for comprehensive primary health care from malaria volunteers in South-East Myanmar: a qualitative study. Malar J. 2021;20(1):19.CrossRef Win Han Oo, Hoban E, Gold L, Kyu Kyu T, Thazin L, Aung T, Fowkes FJI: Community demand for comprehensive primary health care from malaria volunteers in South-East Myanmar: a qualitative study. Malar J. 2021;20(1):19.CrossRef
4.
go back to reference World Health Organization. Eliminating Malaria in the Greater Mekong Subregion: United to End a Deadly Disease. Geneva: World Health Organization; 2016. World Health Organization. Eliminating Malaria in the Greater Mekong Subregion: United to End a Deadly Disease. Geneva: World Health Organization; 2016.
5.
go back to reference World Health Organization: Countries of the Greater Mekong are stepping up to end malaria. In: WHO’s Mekong Malaria Elimination Programme. vol. WHO’s Mekong Malaria Elimination Programme. Geneva: World Health Organization; 2018: 16. World Health Organization: Countries of the Greater Mekong are stepping up to end malaria. In: WHO’s Mekong Malaria Elimination Programme. vol. WHO’s Mekong Malaria Elimination Programme. Geneva: World Health Organization; 2018: 16.
6.
go back to reference World Health Organization. Strategy for malaria elimination in the Greater Mekong Subregion: 2015–2030. Manila: WHO Regional Office for the Western Pacific; 2015. World Health Organization. Strategy for malaria elimination in the Greater Mekong Subregion: 2015–2030. Manila: WHO Regional Office for the Western Pacific; 2015.
7.
go back to reference World Health Organization. Countries of the Greater Mekong zero in on falciparum malaria; 2019. World Health Organization. Countries of the Greater Mekong zero in on falciparum malaria; 2019.
8.
go back to reference Nofal SD, Peto TJ, Adhikari B, Tripura R, Callery J, Bui TM, von Seidlein L, Pell C. How can interventions that target forest-goers be tailored to accelerate malaria elimination in the Greater Mekong Subregion? A systematic review of the qualitative literature. Malar J. 2019;18(1):32–32.CrossRef Nofal SD, Peto TJ, Adhikari B, Tripura R, Callery J, Bui TM, von Seidlein L, Pell C. How can interventions that target forest-goers be tailored to accelerate malaria elimination in the Greater Mekong Subregion? A systematic review of the qualitative literature. Malar J. 2019;18(1):32–32.CrossRef
9.
go back to reference Guyant P, Canavati SE, Chea N, Ly P, Whittaker MA, Roca-Feltrer A, Yeung S. Malaria and the mobile and migrant population in Cambodia: a population movement framework to inform strategies for malaria control and elimination. Malar J. 2015;14:252.CrossRef Guyant P, Canavati SE, Chea N, Ly P, Whittaker MA, Roca-Feltrer A, Yeung S. Malaria and the mobile and migrant population in Cambodia: a population movement framework to inform strategies for malaria control and elimination. Malar J. 2015;14:252.CrossRef
10.
go back to reference World Health Organization. Population mobility and malaria. New Delhi: World Health Organization, Regional Office for South-East Asia; 2017. World Health Organization. Population mobility and malaria. New Delhi: World Health Organization, Regional Office for South-East Asia; 2017.
11.
go back to reference National Malaria Control Programme. National Strategic Plan for Malaria Elimination (2021–2025): Department of Public Health. Ministry of Health and Sports: Republic of the Union of Myanmar; 2019 National Malaria Control Programme. National Strategic Plan for Malaria Elimination (2021–2025): Department of Public Health. Ministry of Health and Sports: Republic of the Union of Myanmar; 2019
12.
go back to reference Center for Malaria Parasitology and Entomology. National Strategic Plan for Malaria Control and Elimination 2016–2020. Vientiane Capital, Lao PDR: Ministry of Health; 2016. Center for Malaria Parasitology and Entomology. National Strategic Plan for Malaria Control and Elimination 2016–2020. Vientiane Capital, Lao PDR: Ministry of Health; 2016.
13.
go back to reference National Center for Parasitology Entomology and Malaria Control. The National Strategic Plan For Elimination of Malaria in the Kingdom of Cambodia 2011–2025. Phnom Penh, Cambodia: Ministry of Health; 2011. National Center for Parasitology Entomology and Malaria Control. The National Strategic Plan For Elimination of Malaria in the Kingdom of Cambodia 2011–2025. Phnom Penh, Cambodia: Ministry of Health; 2011.
14.
go back to reference Hii J, Rueda LM. Malaria vectors in the Greater Mekong Subregion: overview of malaria vectors and remaining challenges. Southeast Asian J Trop Med Public Health. 2013;44:73–165.PubMed Hii J, Rueda LM. Malaria vectors in the Greater Mekong Subregion: overview of malaria vectors and remaining challenges. Southeast Asian J Trop Med Public Health. 2013;44:73–165.PubMed
15.
go back to reference Williams YA, Tusting LS, Hocini S, Graves PM, Killeen GF, Kleinschmidt I, Okumu FO, Feachem RGA, Tatarsky A, Gosling RD. Expanding the vector control toolbox for malaria elimination: a systematic review of the evidence. Adv Parasitol. 2018;99:345–79.CrossRef Williams YA, Tusting LS, Hocini S, Graves PM, Killeen GF, Kleinschmidt I, Okumu FO, Feachem RGA, Tatarsky A, Gosling RD. Expanding the vector control toolbox for malaria elimination: a systematic review of the evidence. Adv Parasitol. 2018;99:345–79.CrossRef
16.
go back to reference Agius PA, Cutts JC, Han W, Thi A, Flaherty K, Zayar K, Kyaw TH, Poe AP, Mon TM, Nyi ZN, et al. Evaluation of the effectiveness of topical repellent distributed by village health volunteer networks against Plasmodium spp. infection in Myanmar: A stepped-wedge cluster randomised trial. PLoS Med. 2020;17(8):e1003177.CrossRef Agius PA, Cutts JC, Han W, Thi A, Flaherty K, Zayar K, Kyaw TH, Poe AP, Mon TM, Nyi ZN, et al. Evaluation of the effectiveness of topical repellent distributed by village health volunteer networks against Plasmodium spp. infection in Myanmar: A stepped-wedge cluster randomised trial. PLoS Med. 2020;17(8):e1003177.CrossRef
17.
go back to reference Thang ND, Erhart A, Speybroeck N, Xa NX, Thanh NN, Ky PV, le Hung X, le Thuan K, Coosemans M, D’Alessandro U. Long-Lasting Insecticidal Hammocks for controlling forest malaria: a community-based trial in a rural area of central Vietnam. PLoS ONE. 2009;4(10): e7369.CrossRef Thang ND, Erhart A, Speybroeck N, Xa NX, Thanh NN, Ky PV, le Hung X, le Thuan K, Coosemans M, D’Alessandro U. Long-Lasting Insecticidal Hammocks for controlling forest malaria: a community-based trial in a rural area of central Vietnam. PLoS ONE. 2009;4(10): e7369.CrossRef
18.
go back to reference Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, Griffey R, Hensley M. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011;38(2):65–76.CrossRef Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, Griffey R, Hensley M. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011;38(2):65–76.CrossRef
19.
go back to reference O’Flaherty K, Oo WH, Zaloumis SG, Cutts JC, Aung KZ, Thein MM, Drew DR, Razook Z, Barry AE, Parischa N, et al. Community-based molecular and serological surveillance of subclinical malaria in Myanmar. BMC Med. 2021;19(1):121.CrossRef O’Flaherty K, Oo WH, Zaloumis SG, Cutts JC, Aung KZ, Thein MM, Drew DR, Razook Z, Barry AE, Parischa N, et al. Community-based molecular and serological surveillance of subclinical malaria in Myanmar. BMC Med. 2021;19(1):121.CrossRef
20.
go back to reference Lautu-Gumal D, Razook Z, Koleala T, Nate E, McEwen S, Timbi D, Hetzel MW, Lavu E, Tefuarani N, Makita L, et al. Surveillance of molecular markers of Plasmodium falciparum artemisinin resistance (kelch13 mutations) in Papua New Guinea between 2016 and 2018. Int J Parasitol Drugs Drug Resist. 2021;16:188–93.CrossRef Lautu-Gumal D, Razook Z, Koleala T, Nate E, McEwen S, Timbi D, Hetzel MW, Lavu E, Tefuarani N, Makita L, et al. Surveillance of molecular markers of Plasmodium falciparum artemisinin resistance (kelch13 mutations) in Papua New Guinea between 2016 and 2018. Int J Parasitol Drugs Drug Resist. 2021;16:188–93.CrossRef
21.
go back to reference Williams GS, Mweya C, Stewart L, Mtove G, Reyburn H, Cook J, Corran PH, Riley EM, Drakeley CJ. Immunophoretic rapid diagnostic tests as a source of immunoglobulins for estimating malaria sero-prevalence and transmission intensity. Malar J. 2009;8:168.CrossRef Williams GS, Mweya C, Stewart L, Mtove G, Reyburn H, Cook J, Corran PH, Riley EM, Drakeley CJ. Immunophoretic rapid diagnostic tests as a source of immunoglobulins for estimating malaria sero-prevalence and transmission intensity. Malar J. 2009;8:168.CrossRef
22.
go back to reference Loudon K, Treweek S, Sullivan F, Donnan P, Thorpe KE, Zwarenstein M. The PRECIS-2 tool: designing trials that are fit for purpose. BMJ : British Medical Journal. 2015;350: h2147.CrossRef Loudon K, Treweek S, Sullivan F, Donnan P, Thorpe KE, Zwarenstein M. The PRECIS-2 tool: designing trials that are fit for purpose. BMJ : British Medical Journal. 2015;350: h2147.CrossRef
23.
go back to reference Brown CA, Lilford RJ. The stepped wedge trial design: a systematic review. BMC Med Res Methodol. 2006;6(1):54.CrossRef Brown CA, Lilford RJ. The stepped wedge trial design: a systematic review. BMC Med Res Methodol. 2006;6(1):54.CrossRef
24.
go back to reference Haines TP, Hemming K. Stepped-wedge cluster-randomised trials: level of evidence, feasibility and reporting. J Physiother. 2018;64(1):63–6.CrossRef Haines TP, Hemming K. Stepped-wedge cluster-randomised trials: level of evidence, feasibility and reporting. J Physiother. 2018;64(1):63–6.CrossRef
25.
go back to reference Hemming K, Taljaard M. Reflection on modern methods: when is a stepped-wedge cluster randomized trial a good study design choice? Int J Epidemiol. 2020;49(3):1043–52.CrossRef Hemming K, Taljaard M. Reflection on modern methods: when is a stepped-wedge cluster randomized trial a good study design choice? Int J Epidemiol. 2020;49(3):1043–52.CrossRef
26.
go back to reference Hemming K, Taljaard M, Grimshaw J. Introducing the new CONSORT extension for stepped-wedge cluster randomised trials. Trials. 2019;20(1):68.CrossRef Hemming K, Taljaard M, Grimshaw J. Introducing the new CONSORT extension for stepped-wedge cluster randomised trials. Trials. 2019;20(1):68.CrossRef
27.
go back to reference Woertman W, Hoop E, Moerbeek M, Zuidema SU, Gerritsen DL, Teerenstra S. Stepped wedge designs could reduce the required sample size in cluster randomized trials. J Clin Epidemiol. 2013;66(7):752–8.CrossRef Woertman W, Hoop E, Moerbeek M, Zuidema SU, Gerritsen DL, Teerenstra S. Stepped wedge designs could reduce the required sample size in cluster randomized trials. J Clin Epidemiol. 2013;66(7):752–8.CrossRef
Metadata
Title
Reducing malaria transmission in forest-going mobile and migrant populations in Lao PDR and Cambodia: protocol for stepped-wedge cluster-randomised controlled trial
Authors
Win Htike
Win Han Oo
Thet Lynn
Lun Sovanda
Paul A. Agius
May Chan Oo
Naw Hkawng Galau
Kaung Myat Thu
Aung Khine Zaw
Ei Phyu Htwe
Julia C. Cutts
Ellen A. Kearney
Nick Scott
Katherine O’Flaherty
Bangyuan Wang
Boualam Khamlome
Phoutnalong Vilay
Sovannaroth Siv
Freya J. I. Fowkes
Publication date
01-12-2022
Publisher
BioMed Central
Keywords
Malaria
Plasmodia
Published in
BMC Infectious Diseases / Issue 1/2022
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-022-07724-5

Other articles of this Issue 1/2022

BMC Infectious Diseases 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.